Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director/PDMR Shareholding

23 Dec 2020 07:00

RNS Number : 6037J
Redcentric PLC
23 December 2020
 

Redcentric plc

 

Director/PDMR Shareholding, Issue of Equity and Total Voting Rights

 

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, announces that on 22 December 2020 it received notification of exercise from each of Peter Brotherton, Chief Executive Officer, and David Senior, Chief Financial Officer, in relation to nil-cost share options ("Options") over ordinary shares of 0.1p each in the Company ("Ordinary Shares"), pursuant to the Company's 2017 Long Term Incentive Plan (the "Exercise"), as follows:

· Peter Brotherton exercised 192,481 Options. Following the Exercise, Mr Brotherton sold 97,481 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Brotherton holds 228,571 Ordinary Shares in the Company (representing approximately 0.15% of the Company's issued share capital) and 921,061 share options in the Company;

· David Senior exercised 29,100 Options. Following the Exercise, Mr Senior sold 14,550 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Senior holds 43,121 Ordinary Shares in the Company (representing approximately 0.03% of the Company's issued share capital) and 249,555 shares options in the Company.

Accordingly, application has been made for 221,581 new Ordinary Shares to be issued pursuant to the option exercise to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around the 31 December 2020.

Following Admission, the Company's issued share capital will consist of 156,165,710 Ordinary Shares, 37,569 of which are held in Treasury. For reporting under the FCA's Disclosure Guidance and Transparency Rules, shareholders should exclude any shares held in Treasury and should use the figure of 156,128,141 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company.

Following the Exercise there are options outstanding over 3,891,750 Ordinary Shares, representing 2.49% of the Company's issued share capital.

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

+44 (0)800 983 2522

finnCap Ltd - Nomad and Sole Broker

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0)20 7220 0500

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Peter Brotherton

 

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

192,481 options exercised

22 December 2020

110p

97,481 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Senior

 

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

29,100 options exercised

22 December 2020

110p

14,550 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTTBJTMTTTTPM
Date   Source Headline
31st May 202411:46 amRNSForm 8.5 (EPT/NON-RI)
31st May 20249:23 amPRNForm 8.3 - Redcentric Plc
30th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
30th May 202410:34 amRNSForm 8.5 (EPT/NON-RI)
30th May 20249:49 amPRNForm 8.3 - Redcentric Plc
29th May 20243:13 pmRNSForm 8.3 - Redcentric PLC
29th May 202411:43 amRNSForm 8.5 (EPT/NON-RI)
29th May 20249:30 amPRNForm 8.3 - Redcentric Plc
29th May 20247:00 amRNSForm 8.3 - Redcentric plc
28th May 20245:17 pmRNSForm 8.3 - Redcentric plc
28th May 20243:57 pmRNSForm 8.3 - Redcentric plc
28th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
28th May 20242:28 pmRNSSI Redstone LLP - Form 8.3 - Redcentric plc
28th May 20241:35 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
28th May 20241:16 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
28th May 202411:49 amRNSForm 8.3 - Redcentric plc
28th May 202411:06 amRNSForm 8.3 - Redcentric PLC
28th May 202410:24 amRNSForm 8.5 (EPT/NON-RI)
28th May 20249:56 amPRNCorrection: Statement regarding Redcentric plc ("Redcentric")
28th May 20249:13 amPRNStatement regarding Redcentric plc ("Redcentric")
24th May 20244:19 pmRNSResponse to press speculation
16th May 20247:00 amRNSTrading Update
14th May 20241:00 pmRNSExercise of Options
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.